Xylem (XYL) Accumulated Expenses (2010 - 2026)

Xylem's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 1.29% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 1.29% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 2.68% from the prior year.
• Accumulated Expenses fell to $1.2 billion in Q1 2026 per XYL's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.3 billion in Q4 2024 and bottomed at $713.0 million in Q1 2022.
• The 5-year median for Accumulated Expenses is $1.1 billion (2024), against an average of $1.1 billion.
• Across the five-year window, Accumulated Expenses surged 40.83% in 2023 and slipped 4.74% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $867.0 million in 2022, then jumped by 40.83% to $1.2 billion in 2023, then gained by 4.1% to $1.3 billion in 2024, then retreated by 2.68% to $1.2 billion in 2025, then decreased by 4.45% to $1.2 billion in 2026.
• Per Business Quant, the three latest XYL Accumulated Expenses figures stand at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025).